type here...

You've selected the tag: FDA

Editors Choice

With RFK Jr. in Charge, Supplement Makers See Chance To Cash In

Medika Life -
Editors Choice

Real-World Evidence Unlocks Consumer Voice to Improve Care

Gil Bashe, Medika Life Editor -
Editors Choice

Groundbreaking Study Reveals Single LSD Dose Offers Instant and Sustained Anxiety Relief

Michael Hunter, MD -
Editors Choice

PFAS Is a Culprit Affecting Health, and It’s in Packaging — But No More in the USA

Pat Farrell PhD -
Editors Choice

Questions About FDA Protection From Dangerous Beauty Products

Pat Farrell PhD -
Editors Choice

Restoring Credibility. Can We Ever Trust Healthcare Again?

Robert Turner, Founding Editor -
Editors Choice

Policies and Policing Didn’t Stem Opioid Abuse – Can Tech Be A Solution?

Gil Bashe, Medika Life Editor -
Healthcare Policy and Opinion

Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?

Medika Life -
Editors Choice

Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug

Medika Life -
Healthcare Policy and Opinion

Were the Billions Invested in Alzheimer’s Research Worthwhile?

Gil Bashe, Medika Life Editor -
Coronavirus

COVID-19 Misinformation, Anti-Science, and Conspiracies Theories

Stephen Schimpff, MD MACP -
Neurological

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
12Page 1 of 2

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories